| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| HLA-A*0201 & B2M & HER2 (LIAHNQVRQV) | Biotinylated Human HLA-A*02:01&B2M&HER2 (LIAHNQVRQV) Complex Protein (Monomer, MALS verified) |  Human | HEK293 | MALSSDS-PAGE | $125.00 25ug |   |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| NC-318 | NC-318; 5G-12 | Phase 2 Clinical | Yale School Of Medicine | Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Small Cell Lung Carcinoma; Carcinoma, Transitional Cell; Cholangiocarcinoma; Breast Neoplasms; Endometrial Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
| DS-1501 | DS-1501 | Phase 1 Clinical | Daiichi Sankyo Co Ltd | Osteoporosis | Details |
| PYX-106 | PYX-106; BSI-060T | Phase 1 Clinical | Boaoxin Biotechnology(Nanjing) Co Ltd | Solid tumours; Neoplasm Metastasis | Details |
